Cover Image

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

Abstract Background Diffuse large B cell lymphoma (DLBCL) is an aggressive and molecularly heterogeneous non-Hodgkin's lymphoma. The B cell receptor (BCR) signaling pathway in DLBCL emerges as a new drug target. Protein phosphatase SHP-1 negatively regulates several oncogenic tyrosine kinases a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ji-Lin Chen (Author), Pei-Yi Chu (Author), Chun-Teng Huang (Author), Tzu-Ting Huang (Author), Wan-Lun Wang (Author), Yu-Hsuan Lee (Author), Yuan-Ya Chang (Author), Ming-Shen Dai (Author), Chung-Wai Shiau (Author), Chun-Yu Liu (Author)
Format:	Book
Published:	BMC, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dihydroarteannuin Ameliorates Collagen-Induced Arthritis Via Inhibiting B Cell Activation by Activating the FcγRIIb/Lyn/SHP-1 Pathway
by: Congqi Hu, et al.
Published: (2022)

Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
by: Jung-Chen Su, et al.
Published: (2018)

Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells
by: Xi Dai, et al.
Published: (2018)

Targeted Delivery of the HLA-B∗27-Binding Peptide into the Endoplasmic Reticulum Suppresses the IL-23/IL-17 Axis of Immune Cells in Spondylarthritis
by: Hui-Chun Yu, et al.
Published: (2017)

Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype
by: Vijaya Gadage, et al.
Published: (2011)

Palatal diffuse large B-cell lymphoma masquerading as an infiltrative bony mass
by: Jyh-Ching Chen, et al.
Published: (2013)

Primary diffuse large B-cell lymphoma of the mandible
by: Juliana Mota Siqueira, et al.
Published: (2019)

Interfering microRNA-410 attenuates atherosclerosis via the HDAC1/KLF5/IKBα/NF-κB axis
by: Shanji Nan, et al.
Published: (2021)

SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
by: Pan Zhou, et al.
Published: (2022)

Primary diffuse large cell B-cell lymphoma of the soft tissue (leg)
by: Tadashi Terada, M.D., Ph.D
Published: (2016)

KRAS Q61H Mutation Confers Cancer Cells with Acquired Resistance to SHP2 Inhibition
by: Yi-Hui Song, et al.
Published: (2022)

Diffuse large B cell lymphoma of the cervix with rectal involvement
by: Elena Igwe, et al.
Published: (2014)

Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
by: Maria Cristina Pirosa, et al.
Published: (2024)

Diffuse large B-cell lymphoma presenting in the leukemic phase
by: Patricia Puccetti Pires, et al.
Published: (2016)

Non-diffuse Large B-cell Lymphoma. Case Presentation
by: Miguel Ángel Serra Valdés, et al.
Published: (2019)

A Rare Tumor of Breast - Diffuse B-Cell Lymphoma
by: Shruthi Kamal Venkataraman, et al.
Published: (2024)

Non-diffuse Large B-cell Lymphoma. Case Presentation
by: Miguel Ángel Serra Valdés, et al.
Published: (2019)

Two Cases of Pelvic Diffuse Large B-Cell Lymphoma
by: Rupam Sharma MD, et al.
Published: (2022)

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone
by: Shachar Kenan, et al.
Published: (2018)

The current status and future trends of BTK inhibitor for diffuse large B cell lymphoma
by: Qiuni Chen, et al.
Published: (2024)

Signet ring cell-like diffuse large B-cell lymphoma involving the breast: a case report
by: Lu Zhang, et al.
Published: (2023)

SHP2-Mediated Signal Networks in Stem Cell Homeostasis and Dysfunction
by: Chen Kan, et al.
Published: (2018)

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma
by: Cong Xu, et al.
Published: (2022)

Diagnostic difficulty of a mandibular manifestation of diffuse large B-cell lymphoma: a case report
by: Huang Samuel, et al.
Published: (2021)

Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013)

Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
by: Janet Ofelia Guevara-Canales, et al.
Published: (2013)

Primary cutaneous diffuse large B-cell lymphoma of the upper limb
by: Srinivasan R, et al.
Published: (2006)

Subcutaneous nodules in a patient with diffuse large B‐cell lymphoma
by: Benjamin Liang Jun Lui, et al.
Published: (2024)

A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma
by: Mary Awad, et al.
Published: (2020)

Diffuse large B-cell lymphoma of the kidney: A rare neoplasm
by: Ram Narayan Das, et al.
Published: (2013)

Primary diffuse cutaneous large B-cell lymphoma, anaplastic type
by: S. V. Antonyuk, et al.
Published: (2012)

Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma
by: Subhashis Mitra, et al.
Published: (2016)

Identification of prognostic factors in patients with diffuse large B-cell lymphoma
by: Fang Peng, et al.
Published: (2017)

Unusual Presentation of Diffuse Large B-Cell Lymphoma With Splenic Infarcts
by: Vivek Kumar MD, et al.
Published: (2017)

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia
by: Camillo Porta, et al.
Published: (2011)

Interfering with the AKT/mTOR/STAT3/ID1 signaling axis with usenamine A restrains the proliferative and invasive potential of human hepatocellular carcinoma cells
by: Ailin Yang, et al.
Published: (2024)

Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation
by: Qian Huang, et al.
Published: (2021)

Two cases of spindle cell variant diffuse large B-cell lymphoma of the uterine cervix
by: Hiroko Murata, et al.
Published: (2020)

Follicular lymphoma evolving into diffuse large B-cell lymphoma with Reed-Sternberg like cells
by: Sankalp Sancheti, et al.
Published: (2015)

High <it>MET</it> gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma
by: Huang Wan-Ting, et al.
Published: (2013)